Avestar Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,872
Closed -$385K 494
2021
Q4
$385K Sell
6,872
-18,490
-73% -$1.13M 0.05% 294
2021
Q3
$1.65M Buy
25,362
+700
+3% +$47.8K 0.21% 110
2021
Q2
$1.56M Buy
24,662
+4,066
+20% +$240K 0.21% 129
2021
Q1
$1.3M Buy
20,596
+9,386
+84% +$510K 0.29% 73
2020
Q4
$560K Buy
11,210
+4,654
+71% +$219K 0.16% 118
2020
Q3
$327K Buy
+6,556
New +$274K 0.11% 148

Other funds holding AXNX

Avestar Capital's AXNX Position: Q1 2022 in Review

Avestar Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 6,872 shares — an estimated $385K sold.

Avestar Capital first reported a position in AXNX in Q3 2020 and held it in 6 quarters. The position peaked at $1.65M in Q3 2021. 186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

  • Avestar Capital reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Avestar Capital sold 6,872 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $385K.
  • Avestar Capital first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Avestar Capital's Axonics, Inc. Common Stock position peaked at $1.65M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Avestar Capital's 13F filing for Q1 2022, filed 26 Apr 2022.